LABRYS BIOLOGICS
Labrys Biologics Inc., a company focused on treatments for chronic migraine. Labrys Biologics has acquired worldwide rights to RN-307 from Pfizer Inc. RN-307 is an antibody for the treatment of chronic migraine.
LABRYS BIOLOGICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2012-01-01
Address:
San Francisco, California, United States
Country:
United States
Total Employee:
11+
Status:
Active
Total Funding:
45.59 M USD
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
KBP Biosciences
A multinational clinical stage biotechnology company.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Investors List
Canaan Partners
Canaan Partners investment in Series A - Labrys Biologics
Sofinnova Investments
Sofinnova Investments investment in Series A - Labrys Biologics
venBio Partners
venBio Partners investment in Series A - Labrys Biologics
InterWest Partners
InterWest Partners investment in Series A - Labrys Biologics
InterWest Partners
InterWest Partners investment in Venture Round - Labrys Biologics
Canaan Partners
Canaan Partners investment in Venture Round - Labrys Biologics
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Labrys Biologics
More informations about "Labrys Biologics"
Labrys Biologics 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Labrys Biologics. Use the PitchBook Platform to explore the full profile.See details»
Teva to Acquire Labrys Biologics, Inc.: Novel Migraine Prophylaxis ...
Jun 3, 2014 Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) and Labrys Biologics, Inc., a …See details»
Organization | Labrys Biologics, Inc.
Labrys Biologics, Inc. Report issue For profit Founded: San Mateo CA United States (2012) …See details»
Labrys Biologics - Products, Competitors, Financials, Employees ...
About Labrys Biologics Labrys Biologics is a private, venture-financed development stage …See details»
Labrys Biologics - Ownership and Business Overview | Mergr
Labrys Biologics is a private, venture-financed development stage biotechnology company …See details»
Teva Pharmaceutical Industries Limited Buys Privately Held Labrys ...
Jun 3, 2014 Teva to Acquire Labrys Biologics, Inc.: Novel Migraine Prophylaxis Treatment …See details»
Labrys Biologics Company Profile | Management and Employees …
Find contact information for Labrys Biologics. Learn about their Research & Development, …See details»
Labrys Biologics - VentureRadar
"Labrys Biologics is a private, venture-financed development stage biotechnology company …See details»
Labrys Biologics - Overview, News & Similar companies - ZoomInfo
Labrys Biologics is a private, venture-financed development stage biotechnology company …See details»
Labrys Biologics Inc - Company Profile and News
Oct 9, 2012 Company profile page for Labrys Biologics Inc including stock price, company …See details»
Labrys Biologics, Inc. (Labrys Biologics, Inc.) - 药物管线_专利_临床 …
Aug 14, 2025 了解Labrys Biologics, Inc. (Labrys Biologics, Inc.)公司的药物管线，治疗领域， …See details»
Labrys Biologics - Financial Details - Crunchbase
Labrys Biologics was acquired by Teva Pharmaceuticals for $825M on Jun 3, 2014. This deal …See details»
Teva to Buy Labrys Biologics - Yahoo Finance
Jun 4, 2014 Teva Pharmaceutical Industries Ltd. (TEVA) will acquire development-stage …See details»
Labrys Biologics - Recent News & Activity - Crunchbase
Labrys Biologics develops treatments for chronic migraine.Recent News & Activity Edit Recent …See details»
Teva acquires Labrys Biologics for up to $825m - Globes
Labrys Biologics focuses on treatments for chronic and episodic migraine. Teva …See details»
Startup Labrys raises Series A funds and buys Pfizer's CGRP inhibitor
Jan 3, 2013 San Francisco-based startup Labrys Biologics simultaneously closed the first …See details»
Labrys Biologics - Growth Outlook - Crunchbase
Labrys Biologics develops treatments for chronic migraine.Growth Score - The measure of …See details»
Teva Announces Labrys Biologics Acquisition | Pharma …
Jun 3, 2014 With the goal of becoming a global leader in pain by 2020, the Labrys acquisition …See details»
Labrys Biologics - Tech Details - Crunchbase
Labrys Biologics develops treatments for chronic migraine.Acquired by Founded 2012Private …See details»
Labrys Biologics - Updates, News, Events, Signals & Triggers
Labrys Biologics develops treatments for chronic migraine.Labrys Biologics may be growing as …See details»